CAPN3 and polymyositis: In pathology group 6, we identified CAPN3 mutations (LGMD2A) in five patients from four families with onset in the early teens and age at loss of walking ability in the third to fourth decades of life except for one patient who had later onset and slower progression and had been misdiagnosed as having polymyositis and been treated with steroids for several years.